Although the inability of patients with Addison's disease to excrete a water load is well known, the nature of this defect remains obscure. The effects of changing glomerular filtration rate (GFR) and solute excretion (UosmV) on water excretion in patients with adrenal insufficiency have recently been described (1) . While an increase in these two variables leads to an increase in the excretion of water, the improvement is very small compared with that seen with carbohydrate-active steroids.
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In healthy persons expansion of the volume of extracellular fluid may increase the rate of excretion of solute-free water (CH2o) (2, 3) . In patients with Addison's disease, when replacement therapy is stopped, the increase in urinary sodium excretion leads to a depletion of body fluids, and continues despite this depletion. It is possible that depletion of the volume of extracellular fluid (ECF) could limit the rate at which water is excreted. These experiments were designed to explore the effects of contraction and expansion of the volume of ECF on water excretion in adrenal insufficiency.
Experiments on effects of increases in solute excretion on CHIo are also presented to clarify further the mechanism whereby expansion of volume corrects the impairment in excretion of water. The effects of treatment with cortisol are included for comparison.
METHODS The four subjects of this study ranged in age from 36 to 61 years. All had the clinical features of Addison's disease, and urinary 17-hydroxycorticoids which were below normal and did not increase with adrenocorticotropin (40 U given intravenously over 8 hours, each day -for 5 days). They remained on an air-conditioned metabolic ward and took a normal diet, which was well toler-ated even when they were not receiving treatment. Body weight, determined with metabolic scales daily on arising, was used as a gross approximation of changes in the volume of body fluids. The patients were studied under the following conditions: a) untreated for 4 to 20 days; b) after expansion of ECF with physiologic saline (0.9 per cent); 1 c) after expansion of ECF with saline and treatment with cortisol acetate, 25 mg per day for 3 to 4 days. Saline was given intravenously, beginning 1 to 3 days before a given study. The amount varied from 2 to 5 L per day, as dosage was increased until the body weight indicated that net fluid volume had returned to values comparable with those observed during treatment with cortisol. When body weight on the day of study indicated that the saline given on the previous day had not been retained, an additional 1.5 to 2.5 L was infused before the study.
All studies were done in the morning on fasting patients, after they had received a "priming" water load (200 ml given orally 1 and 2 hours before study). As a water load, solutions containing 4 per cent fructose were infused for five clearance periods, followed immediately by solutions of physiologic saline which were continued until urine flow reached a peak. Solutions containing 4 per cent mannitol were infused on a separate day under conditions a and b only. All solutions contained inulin, and were delivered by a Bowman constant infusion pump at 15 ml per min, with the patient recumbent. Urine was collected by indwelling bladder catheter, with air washes at the end of each 20-minute period; venous blood was obtained at mid-period through an indwelling Cournand needle. The clearance of alkali-stable inulin was measured by the method of Walser, Davidson and Orloff (5), serum and urine sodium by internal standard flame photometer, and osmolality of serum and urine by Bowman osmometer (6) . CH,0 was computed from the formula: CH20 = V -(UosmV/Posm) with a negative value to be understood as TCH20 (7) . Whereas serum was analyzed, the osmolality of serum has been designated in the tables as Posm, in keeping with current usage.
RESULTS
I. Effect on CHO of acute expansion with saline (Table I, Figure 1 ). When treatment was stopped Figure 1 ). The increase in CH2o was not associated with an increase in UosmV except in Patient J.D. (Figure 1 , Table   I ). The GFR was either essentially unchanged by the infusion of saline (A.B., M.T.), or somewhat higher at the end of it (L.G., Figure 1 ).
II. Effect on CH2o of sustained expansion zwith saline (Table II, Figure 2 ). When the patients had been treated with large quantities of isotonic saline given intravenously, the weight loss that follows discontinuation of treatment (Table I) was minimized (Table II) . Under these circumstances fructose produced rises in urine flow and falls in urinary osmolality which were much greater than those produced by fructose in the depleted state and, indeed, were comparable with those produced by saline in the depleted state. C1E2o, which had ranged from 0.3 to 3.2 ml per minute in the control studies, rose in the expanded state to values ranging from 4.4 to 13.4 ml per minute ( Figure 2 , Tables I and II Note that urinary osmolality rises while fructose is still being infused. The increase in C112o during the infusion of saline occurs without an increase in solute excretion, and before the increase in GFR. patients ( Figure 2) ; it did not rise further when the infusate was changed to saline, except in Patient A.B. (Table II) . The higher CH2o during the infusion of fructose in the expanded state was usually associated with a greater excretion of sodium and total solute than was that seen in the depleted state, but it was also observed with a U0smV no greater than that in the depleted state (compare L.G. and M.T. in Tables I and II) . The GFR was higher in every patient during sustained expansion (Table II) .
III. Effect on CHIo of increasing solute excretion in the depleted and expanded states (Table III, Figure 3) . Three of the patients received 4 per cent mannitol intravenously while ECF was contracted, and again while it was expanded with saline. In both states mannitol induced an increase in urine volume and a decrease in urinary osmolality except in L.G., expanded (Table III) . The maximal values for CH20 with mannitol ranged from 1.5 to 2.6 ml per minute in the depleted state, and from 3.1 to 5.5 ml per minute in the expanded state.
In the depleted state, CHO reached maximal values in the third to the fifth period, then fell, together with urine flow, without increase in serum osmolality and despite continued rise in solute excretion (Table III) . In A.B. and L.G. the maximal values for CH20 attained with mannitol (1.7 and 1.5 ml per minute respectively) were less than those observed with either fructose (3.2 and 2.4 ml per minute, respectively) or saline (4.8 and 11.1 ml per minute, respectively) in the depleted state. The excretion of solute (including Na) with mannitol was greater in the depleted state than that with either fructose or saline in a comparably depleted state (compare Tables I and  III) , and greater than that with fructose in the expanded state (compare Tables II and III t Morning body weight before infusion of 2.5 L of saline.
In the expanded state, CH20 continued through-state (4.4, 6.7, and 13.4 ml per minute, respectively; out the administration of mannitol, except in Pa- Figure 3 , Tables I, II , and III). In both states, tient L. G., and was associated with the highest the changes in GFR with infusion of mannitol were rates of sodium and total solute excretion ob-small and variable. The effects of mannitol on served in these studies ( Figure 3) . Nevertheless, CH20, GFR, UNaV and UosmV are summarized the maximal values for CH2O of 3.2, 5.5, and 3.1 and contrasted with those of fructose in Figure 3 .
ml per minute in A.B., J.D., and L.G., respec-IV. Effect on CH20 of sustained expansion with tively, while greater than those seen with either saline and treatment with cortisol (Table IV) . mannitol or fructose in the depleted state, were When the patients had been treated with isotonic less (except in J.D.) than those seen with saline saline, given intravenously, and cortisol, their body in the depleted state (4.8, 4.5, and 11.1 ml per min-weights were comparable with, or greater than, ute, respectively) or with fructose in the expanded those seen with saline alone (compare Tables II   TABLE III Effect of infusion of mannitol on CH20 in patients with ECF volume depleted before and during sustained expansion with saline (Figures 1  and 2 , Table I ).
By administration of large quantities of salt intravenously, it was possible to avoid the loss of weight and the depletion of extracellular fluid that Thus, in Addison's disease, an expansion of ECF, whether produced acutely or sustained, leads to a water diuresis. Moreover, when ECF is depleted, a rapid infusion of fructose or mannitol, each of which expands body fluid volume transiently, promotes an initial, unsustained CH20 (Tables I and III).
An infusion of saline may increase both GFR (8), and solute excretion, two of the variables important in the formation of solute-free water (9) . As previously shown for untreated patients with Addison's disease (10), the GFR was low in these patients when they were not receiving cortisol-like steroids and saline. A reduction in GFR may well contribute to the defective CH20: acute reduction in GFR can abolish a water diuresis in both dog (11) and man (12, 13) . Conversely, the rise in GFR after administration of aminophylline in adrenal insufficiency is accompanied by a rise in CH2O (1) .-Whereas a higher GFR was usually found together with the improved CH20 after sustained salt loading (compare Tables I and II) , CTI2o frequently improved before any change in GFR (Figure 1 ) or with only a small change after acute salt loading (Table I) (18) . Moreover, when neurohypophyseal insufficiency complicates adrenal insufficiency, one may find an impairment in the conservation of water (dilute urine associated with hypertonic serum) rather than in its excretion (19) ; serum sodium concentrations do not decrease significantly (20) .
In the present studies the rise of urinary osmolalities to 314, 445, and 433 mOsm per L during the infusion of fructose in Patients J.D., L.G., and M.T., respectively, while the volume of ECF was depleted (Table I) , may be attributable to an increased secretion of ADH. Although saline could produce CH20 in the presence of small quantities of ADH by increasing solute excretion (21, 22) , the relative ineffectiveness of mannitol as well as the frequent increase of CE120 before an increase in UosmV suggests that such an effect will not explain the diuresis seen in our studies.
On the other hand, the expansion of ECF volume that is induced by infusion of saline may serve to decrease secretion or release of ADH. In normal subjects the infusion of isotonic saline (2) and of iso-and hyperoncotic albumin (3) 
